会社概要
- 正式社名: Yaohai Biotechnology (Beijing) Co.,Ltd
- 登録国: China
- 住所: 4th Floor, Building 1, Zhongguan Science and Technology Park, No.25 Yongxing Road, Daxing District, Beijing
- 従業員数: 250 - 499
- 設立年: 2010
説明:
As a CRTDMO (Contract Research, Testing, Development and Manufacturing Organization) focused on microbial expression systems, Yaohai provides one-stop, end-to-end biopharmaceutical services including manufacturing recombinant proteins, peptides/polypeptides, enzymes, antibody fragments, plasmid DNA and mRNA. The company also provides long (IVT) RNA production services, operating a cGMP production platform with fermentation scale exceeding 7,500L, making it the largest GMP-level plasmid supplier in China, capable of meeting clinical and commercial needs.
事業活動
受託・アウトソーシングサービス
医薬品開発製造受託機関(CDMO)製造業者受託製造業者(CMO)
天然抽出物・生薬原料
製造業者受託製造業者(CMO)
受託包装サービス
製造業者受託製造業者(CMO)
ATC分類(解剖治療化学分類)
製造業者受託製造業者(CMO)
先発品原薬
製造業者受託製造業者(CMO)
販売市場
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Melanesia: Papua New Guinea
- Western Asia: United Arab Emirates, Armenia, Azerbaijan, Bahrain, Cyprus, Georgia, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman
主要製品/サービス
- 受託・アウトソーシングサービス: Biosimilars, vaccines and diagnostics CRDMO for human and veterinary use, Biological therapeutics CRDMO
- バイオ医薬品: Recombinant protein/mRNA CDMO services, Novel recombinant vaccines
- バイオ医薬品サービス: Aesthetic medicine CMO / Ingredient Supply: Collagen, BTX;GLP-1 / semaglutide / Liraglutide: CMO / Ingredient Supply;Agrochemicals CMO;
当社の製品・サービス
Sell · Biopharmaceutical Services
認証
EU QP audited
GMP
ISO
証明
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
評価
(0)
(0)
(0)
(0)
(0)
コメント
フィルター:
並べ替え:
コメントはありません。
評価とコメントを残す